Indigo is set to disrupt the growing Continuous Glucose Monitor (CGM) market with a long-term insertable optical microchip.
Indigo’s solution will answer the patient’s need for a hassle-free, invisible CGM without a body-worn device and will address the physician’s quest for a multi-biomarker sensor that also measures lactate and ketones besides just glucose. Personalised diabetes management will be brought to the next level with Indigo’s groundbreaking technology.
